Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer

BACKGROUND: Although the 21-gene recurrence score (RS) assay is widely used to predict distant recurrence risk and benefit from adjuvant chemotherapy among women with hormone receptor-positive (HR+) breast cancer, the relationship between the RS and isolated locoregional recurrence (iLRR) remains po...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, David D., Buscariollo, Daniela L., Cronin, Angel M., Weng, Shicheng, Hughes, Melissa E., Bleicher, Richard J., Cohen, Adam L., Javid, Sara H., Edge, Stephen B., Moy, Beverly, Niland, Joyce C., Wolff, Antonio C., Hassett, Michael J., Punglia, Rinaa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429461/
https://www.ncbi.nlm.nih.gov/pubmed/32799886
http://dx.doi.org/10.1186/s13014-020-01640-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429461/
https://www.ncbi.nlm.nih.gov/pubmed/32799886
http://dx.doi.org/10.1186/s13014-020-01640-1

Ejemplares similares